The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 331:450-459 August 18, 1994 Number 7
NextNext

Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection
Patrick G. O'Connor, Peter A. Selwyn, and Richard S. Schottenfeld

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Injection-drug use has become an important risk factor for infection with the human immunodeficiency virus (HIV), and HIV infection has become well established among drug users in North America, Europe, South America, and Southeast Asia1,2,3. In the United States, approximately 34 percent of all the cases of the acquired immunodeficiency syndrome (AIDS) in adults have occurred either in injection-drug users or in their sexual contacts. The proportion of the AIDS epidemic that is related to injection-drug use has increased steadily over the past decade,2,3 and it is particularly high among women and ethnic minorities3. In addition, the spectrum . . . [Full Text of this Article]

Screening for and Diagnosis of Substance Abuse

History

Physical Examination

Laboratory Tests

The Spectrum of HIV-Related Diseases in Injection-Drug Users

Bacterial Infections

Tuberculosis

Sexually Transmitted Diseases

Hepatitis

Other Retroviral Infections

Cancer

Revised Case Definition of AIDS

Substance Abuse and the Differential Diagnosis of HIV-Related Symptoms

Constitutional Symptoms

Pulmonary Symptoms

Neurologic Symptoms

Dermatologic and Other Symptoms

Clinical Issues in the Care of Injection-Drug Users with HIV Infection

Preventive Health Care

Referral of Patients for Treatment of Substance Abuse

Drug Interactions

Issues in Women's Health Care

Psychosocial Issues in the Care of Injection-Drug Users with HIV Infection

Access to Care and Compliance with Treatment

Psychiatric Illness and Cognitive Dysfunction

Prescription of Psychoactive Medications

Physician-Patient Interactions

            Potential Conflicts

            Productive Physician-Patient Interactions

Challenges for the Future


Source Information

From the Departments of Medicine (P.G.O., P.A.S.) and Psychiatry (R.S.S.), Yale University School of Medicine, New Haven, Conn.

Address reprint requests to Dr. O'Connor at the Primary Care Center, Yale University School of Medicine, P.O. Box 208025, New Haven, CT 06520-8025.

References


Related Letters:

The Care of Injection-Drug Users with HIV Infection
Newman R. G., Selbovitz L. G., Zide-Selbovitz L., Blansfield H. N., O'Connor P. G., Selwyn P. A., Schottenfeld R. S.
Extract | Full Text  
N Engl J Med 1994; 331:1773-1774, Dec 29, 1994. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.